Key facts
- Notable investors include z21 Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Humigent
- ·The full record, as it builds
Funding rounds
No funding rounds for Humigent are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Humigent
Provider of Agentic AI and Advanced Analytics designed for bridging the gap between complex pharmaceutical data and confident, compliant business decisions. The company offers an AI platform that leverages domain-first expertise and a proprietary smart workbench, enabling clients to transition from static data reporting to autonomous, predictive action with guaranteed commercial impact.
- Sector
- Information Technology
- HQ
- Iselin, NJ, United States
- Founded
- 2025
- Employees
- 51
- Website
- humigent.ai/
- Ownership
- Privately Held (backing)
Humigent doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Humigent shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Humigent in its N-PORT filings yet. We sweep new filings monthly.